CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a novel platform for personalized drug therapy using implants that release medication on-demand, controlled by blue or UV light. By overcoming the limitations of light penetration in tissues, the technology enables precise drug delivery, enhancing treatment effectiveness in various medical applica…
This proposal introduces a next-generation platform for next generation optimally personalised drug therapy: on-demand drug releasing implants triggered and controlled by blue/UV light.
The technology is based on novel light generation pathways and a light-sensitive nanocellulose drug reservoir.A formidable physiological barrier for light-triggered drug release has been the inability to use high-energy blue/UV light as the triggering signal.
This is because the penetration depth of light drops t…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Finland, Tampere
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
